Literature DB >> 3286634

Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.

F G Oppenheim1, T Xu, F M McMillian, S M Levitz, R D Diamond, G D Offner, R F Troxler.   

Abstract

Histatins 1, 3, and 5 from human parotid secretion were isolated by gel filtration on Bio-Gel P-2 and reverse phase high performance liquid chromatography. The complete amino acid sequences of histatins determined by automated Edman degradation of the proteins, Staphylococcus aureus V8 protease, and tryptic peptides, are as follows: (Sequence: see text). Histatins 1, 3, and 5 contain 38, 32, and 24 amino acid residues, have molecular weights of 4929, 4063, and 3037, respectively, and contain 7 residues of histidine. Histatin 1 contains 1 mol of phosphate/mol of protein; histatins 3 and 5 lack phosphate. With the exception of Glu (residue 4) and Arg (residue 11) in histatin 1, the first 22 amino acid residues of all three histatins are identical, and the carboxyl-terminal 7 residues of histatins 1 and 3 are also identical. The sequence, -Glu-Phe-Pro-Phe-Tyr-Gly-Asp-Tyr-Gly- (residues 23-29), in histatin 1 is absent in histatin 3; and the sequence, -Gly-Tyr-Arg- (residues 23-25), in histatin 3 is absent in histatin 1. The complete sequence of histatin 5 is contained within the amino terminal 24 residues of histatin 3. The structural data suggest that histatins 1 and 3 are derived from different structural genes, whereas histatin 5 is a proteolytic product of histatin 3. All three histatins exhibit the ability to kill the pathogenic yeast, Candida albicans.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286634

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  152 in total

1.  Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.

Authors:  D M Rothstein; P Spacciapoli; L T Tran; T Xu; F D Roberts; M Dalla Serra; D K Buxton; F G Oppenheim; P Friden
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.

Authors:  H Gusman; J Travis; E J Helmerhorst; J Potempa; R F Troxler; F G Oppenheim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.

Authors:  C B Park; K S Yi; K Matsuzaki; M S Kim; S C Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

4.  Amoebapores and NK-lysin, members of a class of structurally distinct antimicrobial and cytolytic peptides from protozoa and mammals: a comparative functional analysis.

Authors:  Heike Bruhn; Beate Riekens; Otto Berninghausen; Matthias Leippe
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

5.  Dialysis unmasks the fungicidal properties of glandular salivary secretions.

Authors:  Eva J Helmerhorst; Bianca Flora; Robert F Troxler; Frank G Oppenheim
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 6.  Epithelial cells and innate antifungal defense.

Authors:  G Weindl; J Wagener; M Schaller
Journal:  J Dent Res       Date:  2010-04-15       Impact factor: 6.116

7.  Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.

Authors:  C Gyurko; U Lendenmann; R F Troxler; F G Oppenheim
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

8.  Host-derived pentapeptide affecting adhesion, proliferation, and local pH in biofilm communities composed of Streptococcus and Actinomyces species.

Authors:  Mirva Drobni; Tong Li; Carina Krüger; Vuokko Loimaranta; Mogens Kilian; Lennart Hammarström; Hans Jörnvall; Tomas Bergman; Nicklas Strömberg
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

9.  Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.

Authors:  Robert Bucki; Dorota B Namiot; Zbigniew Namiot; Paul B Savage; Paul A Janmey
Journal:  J Antimicrob Chemother       Date:  2008-05-01       Impact factor: 5.790

10.  Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus.

Authors:  A Lupetti; J T van Dissel; C P J M Brouwer; P H Nibbering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-20       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.